3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
Lancet Respir Med.
张慧、Huang Chaolin、谷晓颖、王业明、曹彬、张鼎玉
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
The New England journal of medicine
曹彬、王业明、luhongzhou、yang yumei 、王辰
Comparison of influenza‐ and COVID‐19‐associated pulmonary aspergillosis in China.
European Journal of Clinical Microbiology & Infectious Diseases.
赵建康、卓献霞、曹彬、鲁炳怀
In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China.
Antimicrob Agents Chemother .
赵建康、蒲丹妮、曹彬、鲁炳怀
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
EBIOMEDICINE
谷晓颖、wangsiyuan、张婉莹、licaihong、guoli、曹彬、zhangdingyu
"Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China.
SCIENCE BULLETIN
蒲丹妮、 曹彬
Metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid on antimicrobial stewardship in patients with lower respiratory tract infections (LRTIs): a retrospective cohort study.
MICROBIOLOGY SPECTRUM
赵建康、蒲丹妮、曹彬、鲁炳怀
Adapted vaccine strategy: facing the persistent challenges of COVID-19
LANCET INFECTIOUS DISEASES
商潋瀚、曹彬
Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
蒲丹妮、赵建康、曹彬
The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza
ANTIVIRAL RESEARCH